BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $4,778,771 (100.0% shares, 0.0% debt)

Holdings (5)

— CEREVEL THERAPEUTICS HLDNG I 33.5%

Value ($000) $1,603,119 Shares 60,632,356 Est. Cost $16.58 Unrealized —

— DIVERSEY HLDGS LTD 32.7%

Value ($000) $1,561,304 Shares 236,561,159 Est. Cost $14.71 Unrealized —

SGRY SURGERY PARTNERS INC 29.7%

Value ($000) $1,418,948 Shares 49,064,576 Est. Cost $32.73 Unrealized +33.5%

AVAH AVEANNA HEALTHCARE HLDGS INC 3.9%

Value ($000) $184,418 Shares 81,600,880 Est. Cost $11.86 Unrealized -75.6%

ADV ADVANTAGE SOLUTIONS INC 0.2%

Value ($000) $10,982 Shares 2,890,000 Est. Cost $10.52 Unrealized -54.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CEREVEL THERAPEUTICS HLDNG I	60,632,356	$1,603,119	33.5%	$16.58	—	COM	15678U128
—	DIVERSEY HLDGS LTD	236,561,159	$1,561,304	32.7%	$14.71	—	ORD SHS	G28923103
SGRY	SURGERY PARTNERS INC	49,064,576	$1,418,948	29.7%	$32.73	+33.5%	COM	86881A100
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$184,418	3.9%	$11.86	-75.6%	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$10,982	0.2%	$10.52	-54.1%	COM CL A	00791N102